Gossamer Bio SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 28, 2026, 4:02 p.m. ETView on SEC.gov
Submission of matters to a vote of security holders
AI summary, unreviewedGossamer Bio stockholders approve Nasdaq-required share issuance under August 2026 Securities Purchase Agreement, 2,808,000 votes for against 37,814 against
8-KSept. 28, 2026, 4:01 p.m. ETView on SEC.gov
Other events
8-KSept. 23, 2026, 4:05 p.m. ETView on SEC.gov
Other events
8-KSept. 16, 2026, 4:05 p.m. ETView on SEC.gov
Departure/appointment of directors or officers · Financial statements and exhibits
8-KSept. 11, 2026, 8:01 a.m. ETView on SEC.gov
Material modification of security holders' rights · Amendments to articles or bylaws; fiscal year change · Other events · Financial statements and exhibits
8-KSept. 9, 2026, 9 a.m. ETView on SEC.gov
Other events · Financial statements and exhibits
8-KSept. 3, 2026, 4:02 p.m. ETView on SEC.gov
Amendments to articles or bylaws; fiscal year change · Financial statements and exhibits
8-KAug. 26, 2026, 4:01 p.m. ETView on SEC.gov
Amendments to articles or bylaws; fiscal year change · Financial statements and exhibits
8-KAug. 21, 2026, 8:01 a.m. ETView on SEC.gov
Entry into a material definitive agreement · Unregistered sales of equity securities · Amendments to articles or bylaws; fiscal year change · Regulation FD disclosure · Financial statements and exhibits
8-KAug. 13, 2026, 4:02 p.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
8-KJuly 27, 2026, 4:01 p.m. ETView on SEC.gov
Entry into a material definitive agreement · Termination of a material definitive agreement · Results of operations and financial condition · Regulation FD disclosure · Other events · Financial statements and exhibits